Skip to search formSkip to main contentSkip to account menu

MPC 1304

Known as: MPC-1304 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

aranidipine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
1996
Review
1996
Aranidipine (MPC-1304), a New Dihydropyridine Calcium Antagonist: A Review of Its Antihypertensive Action
1996
1996
PHARMACOKINETICS AND PHARMACODYNAMICS OF A NEW CALCIUM CHANNEL BLOCKER MPC‐1304 IN HYPERTENSIVE SUBJECTS
The pharmacokinetic and pharmacodynamic properties of a new calcium channel blocker MPC-1304 (MPC) were examined following a… 
1995
1995
Effects of a new calcium channel blocker, MPC-1304, on blood pressure, serum lipoproteins and serum carbohydrate metabolism in patients with essential hypertension.
The effects of MPC-1304, a new calcium channel blocker, on blood pressure, serum lipoproteins, and carbohydrate metabolism were… 
1994
1994
Effects of MPC-1304, a novel calcium antagonist, on stroke-prone spontaneously hypertensive rats.
The effects of MPC-1304, a newly developed 1,4-dihydropyridine derivative, on blood pressure and hypertensive complications in… 
1993
1993
Cardiovascular Profile of MPC‐1304, a Novel Dihydropyridine Calcium Antagonist: Comparison with Other Calcium Antagonists
The cardiovascular profile of a novel calcium antagonist, MPC-1304 and its active metabolites were investigated in experimental… 
1993
1993
Calcium entry blocking activities of MPC-1304 and of its enantiomers and metabolites.
1993
1993
MPC-1304, another type of dihydropyridine, possessing highly potent vasodilating action.
1992
1992
Antihypertensive Effects of MPC-1304, a Novel Calcium Antagonist, in Experimental Hypertensive Rats and Dogs
Summary: Antihypertensive effects of a novel calcium antagonist, MPC-1304, (±)-methyl 2-oxopropyl 1,4-dihydro-2,6-dimethyl-4-(2… 
1990
1990
Pharmacodynamic and pharmacological effects of MPC-1304, a new calcium channel blocker, in healthy subjects. Results of multiple oral administration.
The pharmacodynamic and pharmacological effects of MPC-1304 after multiple oral administration were studied in a cross-over… 
1986
1986
Synthesis of asymmetric 4-aryl-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylates with vasodilating and antihypertensive activities.
Asymmetric 4-aryl-1, 4-dihydro-2, 6-dimethyl-3, 5-pyridinedicarboxylates with a 2-ethylenedioxypropyl, 2-oxopropyl, or… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)